Peri-Op Management Key in Surgical Resident Malpractice

Share this content:
Peri-Op Management Key in Surgical Resident Malpractice
Peri-Op Management Key in Surgical Resident Malpractice

FRIDAY, Sept. 1, 2017 (HealthDay News) -- The perioperative period appears critical in malpractice cases involving surgical residents, according to a study published online Aug. 30 in JAMA Surgery.

Cornelius A. Thiels, D.O., M.B.A., from the Mayo Clinic in Rochester, Minn., and colleagues collected data on patient demographics, case characteristics, and outcomes from an online legal research database for malpractice cases involving surgical interns, residents, or fellows.

The researchers identified 87 malpractice cases involving surgical trainees during a 10-year period. Overall, 67 cases (77 percent) resulted in death or permanent disability. Sixty-one cases (70 percent) involved elective surgery and named a junior resident as a defendant (69 percent). Cases more often questioned perioperative medical knowledge, decision making errors, and injuries than intraoperative errors and injuries (61 versus 49 percent). The involvement of junior residents was mainly in lawsuits related to medical decision making (87 percent). Ten cases (12 percent) cited residents' failure to evaluate the patients, and lack of direct supervision by attending physicians was mentioned in 48 cases (55 percent). Overall, 48 percent of cases resulted in a jury verdict or settlement in favor of the plaintiff, with a $900,000 median payout.

"This review of malpractice cases involving surgical residents highlights the importance of perioperative management, particularly among junior residents, and the importance of appropriate supervision by attending physicians as targets for education on litigation prevention," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »